Company Update (NASDAQ:CELG): Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2015

[Business Wire] – Celgene Corporation today announced more than 55 presentations reporting on investigational studies in blood and solid tumor cancers will be presented during the 51st American Society of Clinical Oncology meeting . . . → Read More: Company Update (NASDAQ:CELG): Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2015 Similar Articles: Company Update: Celgene Corporation (NASDAQ:CELG) – Phase II Data for Celgene’s Investigational Oral GED-0301 for Patients with Active Crohn’s Disease Published in New England Journal of Medicine Stock Update (NASDAQ:CELG): Celgene Corporation to Webcast at Upcoming Investor Conferences Stock Update (NASDAQ:CELG): Celgene Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference